Human Milk in Preterm Infants
Sponsor
Augusta University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05228535
Collaborator
(none)
50
1
2
19.7
2.5
Study Details
Study Description
Brief Summary
Current NICU protocol introduces human milk fortifier at 8 days of feeding. This study will introduce human milk fortifier at day 1. The primary outcome is the effect on growth velocity at 28 days and 36 weeks post menstrual age.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 groups. 1 group will be controlled, following standard NICU feeding protocol. 1 group will be intervention, receiving early introduction of human milk fortifier to enteral feeds.2 groups. 1 group will be controlled, following standard NICU feeding protocol. 1 group will be intervention, receiving early introduction of human milk fortifier to enteral feeds.
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Early Fortification of Human Milk for Very Low Birth Weight Infants and Effects on Growth Velocity
Actual Study Start Date
:
Apr 11, 2022
Anticipated Primary Completion Date
:
Jul 1, 2023
Anticipated Study Completion Date
:
Dec 1, 2023
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Continue current NICU feeding protocol, introducing human milk fortifier at 8 days |
|
Experimental: Intervention Introducing human milk fortifier at 1 day |
Dietary Supplement: Human milk fortifier
Human milk fortifier added to human breast milk at day 1 vs day 8 of feeds
|
Outcome Measures
Primary Outcome Measures
- Growth velocity [at 28 days of life]
weight gain in grams/kg/day
Secondary Outcome Measures
- Growth velocity [at 36 weeks post menstrual age]
weight gain in grams/kg/day
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 4 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Birth weight 1000-1500 grams
-
Admitted to NICU within 24 hours of life
-
Maternal intent to use human milk
Exclusion Criteria:
-
Congenital anomalies
-
Feeds not started within the first 96 hours of life
-
Intrauterine growth restriction
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Hospital of Georgia | Augusta | Georgia | United States | 30912 |
Sponsors and Collaborators
- Augusta University
Investigators
None specified.Study Documents (Full-Text)
More Information
Publications
None provided.Responsible Party:
Augusta University
ClinicalTrials.gov Identifier:
NCT05228535
Other Study ID Numbers:
- 1813934-2
First Posted:
Feb 8, 2022
Last Update Posted:
Jul 21, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: